Cerebral hyperperfusion syndrome after revascularization surgery in patients with moyamoya disease

References

• Pandey P, Steinberg GK. Neurosurgical advances in the treatment of moyamoya disease. Stroke 2011;42:3304–10.
   PubMed Web of Science ®Google Scholar
• Suzuki J, Kodama N. Moyamoya disease–a review. Stroke 1983;14:104–9.
   PubMed Web of Science ®Google Scholar
• Dusick JR, Gonzalez NR, Martin NA. Clinical and angiographic outcomes from indirect revascularization surgery for Moyamoya disease in adults and children: a review of 63 procedures. Neurosurgery 2011;68:34–43.
   PubMed Web of Science ®Google Scholar
• Okada Y, Kawamata T, Kawashima A, et al. The efficacy of superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease complaining of severe headache. J Neurosurg 2012;116:672–9.
   PubMed Web of Science ®Google Scholar
• Houkin K, Kamiyama H, Abe H, Takahashi A, Kuroda S. Surgical therapy for adult moyamoya disease. Can surgical revascularization prevent the recurrence of intracerebral hemorrhage? Stroke 1996;27:1342–6.
   PubMed Web of Science ®Google Scholar
• Fujimura M, Kaneta T, Shimizu H, Tominaga T. Symptomatic hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in a child with moyamoya disease. Childs Nerv Syst 2007;23:1195–8.
   PubMed Web of Science ®Google Scholar
• Patel NN, Mangano FT, Klimo P Jr. Indirect revascularization techniques for treating moyamoya disease. Neurosurg Clin N Am 2010;21:553–63.
   PubMed Web of Science ®Google Scholar
• Baaj AA, Agazzi S, Sayed ZA, et al. Surgical management of moyamoya disease: a review. Neurosurg Focus 2009;26:E7.
   PubMed Web of Science ®Google Scholar
• Amin-Hanjani S. Cerebral revascularization: extracranial-intracranial bypass. J Neurosurg Sci 2011;55:107–16.
   PubMed Web of Science ®Google Scholar
• Parray T, Martin TW, Siddiqui S. Moyamoya disease: a review of the disease and anesthetic management. J Neurosurg Anesthesiol 2011;23:100–9.
   PubMed Web of Science ®Google Scholar
• Fujimura M, Mugikura S, Kaneta T, Shimizu H, Tominaga T. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. Surg Neurol 2009;71:442–7.
   PubMedGoogle Scholar
• Hayashi K, Horie N, Suyama K, Nagata I. Incidence and clinical feature of symptomatic cerebral hyperperfusion syndrome following vascular reconstruction. World Neurosurg 2011. [Epub ahead of print].
   Web of Science ®Google Scholar
• Uno M, Nakajima N, Nishi K, Shinno K, Nagahiro S. Hyperperfusion syndrome after extracranial-intracranial bypass in a patient with moyamoya disease–case report. Neurol Med Chir (Tokyo) 1998;38:420–4.
   PubMed Web of Science ®Google Scholar
• van Mook WN, Rennenberg RJ, Schurink GW, et al. Cerebral hyperperfusion syndrome. Lancet Neurol 2005;4:877–88.
   PubMed Web of Science ®Google Scholar
• Furuya K, Kawahara N, Morita A, et al. Focal hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease. Case report. J Neurosurg 2004;100:128–32.
   PubMed Web of Science ®Google Scholar
• Morgan MK, Zurin AA, Harrington T, Little N. Changing role for preoperative embolisation in the management of arteriovenous malformations of the brain. J Clin Neurosci 2000;7:527–30.
   PubMed Web of Science ®Google Scholar
• Zacharia BE, Bruce S, Appelboom G, Connolly ES Jr. Occlusive hyperemia versus normal perfusion pressure breakthrough after treatment of cranial arteriovenous malformations. Neurosurg Clin N Am 2012;23:147–51.
   PubMed Web of Science ®Google Scholar
• Fujimura M, Shimizu H, Inoue T, et al. Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography. Neurosurgery 2011;68:957–64.
   PubMed Web of Science ®Google Scholar
• Han JS, Abou-Hamden A, Mandell DM, et al. Impact of extracranial-intracranial bypass on cerebrovascular reactivity and clinical outcome in patients with symptomatic moyamoya vasculopathy. Stroke 2011;42:3047–54.
   PubMed Web of Science ®Google Scholar
• Fujimura M, Kaneta T, Mugikura S, Shimizu H, Tominaga T. Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease. Surg Neurol 2007;67:273–82.
   PubMedGoogle Scholar
• Kawamata T, Kawashima A, Yamaguchi K, Hori T, Okada Y. Usefulness of intraoperative laser Doppler flowmetry and thermography to predict a risk of postoperative hyperperfusion after superficial temporal artery-middle cerebral artery bypass for moyamoya disease. Neurosurg Rev 2011;34:355–62.
   PubMed Web of Science ®Google Scholar
• Fujimura M, Gasche Y, Morita-Fujimura Y, et al. Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res 1999;842:92–100.
   PubMed Web of Science ®Google Scholar
• Ogasawara K, Komoribayashi N, Kobayashi M, et al. Neural damage caused by cerebral hyperperfusion after arterial bypass surgery in a patient with moyamoya disease: case report. Neurosurgery 2005;56:E1380
   PubMed Web of Science ®Google Scholar
• Fujimura M, Shimizu H, Mugikura S, Tominaga T. Delayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: possible involvement of cerebral hyperperfusion and increased vascular permeability. Surg Neurol 2009;71:223–7; discussion 7.
   PubMedGoogle Scholar
• Mesiwala AH, Sviri G, Fatemi N, Britz GW, Newell DW. Long-term outcome of superficial temporal artery-middle cerebral artery bypass for patients with moyamoya disease in the US. Neurosurg Focus 2008;24:E15.
   PubMed Web of Science ®Google Scholar
• Donswijk ML, Jones PS, Guadagno JV, et al. T2*-weighted MRI versus oxygen extraction fraction PET in acute stroke. Cerebrovasc Dis 2009;28:306–13.
   PubMed Web of Science ®Google Scholar
• Schellinger PD, Bryan RN, Caplan LR, et al. Evidence-based guideline: The role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2010;75:177–85.
   PubMed Web of Science ®Google Scholar
• Killeen RP, Mushlin AI, Johnson CE, et al. Comparison of CT perfusion and digital subtraction angiography in the evaluation of delayed cerebral ischemia. Acad Radiol 2011;18:1094–100.
   PubMed Web of Science ®Google Scholar
• Kohama M, Fujimura M, Mugikura S, Tominaga T. Temporal change of 3-T magnetic resonance imaging/angiography during symptomatic cerebral hyperperfusion following superficial temporal artery-middle cerebral artery anastomosis in a patient with adult-onset moyamoya disease. Neurosurg Rev 2008;31: 451–5.
   PubMed Web of Science ®Google Scholar
• Saida T, Masumoto T, Nakai Y, et al. Moyamoya disease: evaluation of postoperative revascularization using multiphase selective arterial spin labeling MRI. J Comput Assist Tomogr 2012;36:143–9.
   PubMed Web of Science ®Google Scholar
• Nakagawa A, Fujimura M, Arafune T, Sakuma I, Tominaga T. Clinical implications of intraoperative infrared brain surface monitoring during superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. J Neurosurg 2009;111:1158–64.
   PubMed Web of Science ®Google Scholar
• Ohue S, Kumon Y, Kohno K, et al. Postoperative temporary neurological deficits in adults with moyamoya disease. Surg Neurol 2008;69:281–6.
   PubMed Web of Science ®Google Scholar
• Ogasawara K, Sakai N, Kuroiwa T, et al. Intracranial hemorrhage associated with cerebral hyperperfusion syndrome following carotid endarterectomy and carotid artery stenting: retrospective review of 4494 patients. J Neurosurg 2007;107:1130–6.
   PubMed Web of Science ®Google Scholar